GB1513916A - Stable ophthalmic formulation - Google Patents
Stable ophthalmic formulationInfo
- Publication number
- GB1513916A GB1513916A GB28847/75A GB2884775A GB1513916A GB 1513916 A GB1513916 A GB 1513916A GB 28847/75 A GB28847/75 A GB 28847/75A GB 2884775 A GB2884775 A GB 2884775A GB 1513916 A GB1513916 A GB 1513916A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ophthalmic
- compositions
- hydroxy
- composition
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 238000009472 formulation Methods 0.000 title 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000007983 Tris buffer Substances 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 229940105329 carboxymethylcellulose Drugs 0.000 abstract 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 abstract 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 abstract 1
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 abstract 1
- 229960004926 chlorobutanol Drugs 0.000 abstract 1
- 239000007979 citrate buffer Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- LNGNZSMIUVQZOX-UHFFFAOYSA-L disodium;dioxido(sulfanylidene)-$l^{4}-sulfane Chemical compound [Na+].[Na+].[O-]S([O-])=S LNGNZSMIUVQZOX-UHFFFAOYSA-L 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229960005150 glycerol Drugs 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 229960003540 oxyquinoline Drugs 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 229940068984 polyvinyl alcohol Drugs 0.000 abstract 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 abstract 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 abstract 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 abstract 1
- 229940033663 thimerosal Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US493751A US3920824A (en) | 1974-08-01 | 1974-08-01 | Stable ophthalmic formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1513916A true GB1513916A (en) | 1978-06-14 |
Family
ID=23961553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB28847/75A Expired GB1513916A (en) | 1974-08-01 | 1975-07-09 | Stable ophthalmic formulation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3920824A (enExample) |
| JP (1) | JPS5138411A (enExample) |
| DE (1) | DE2532017C2 (enExample) |
| FR (1) | FR2280373A1 (enExample) |
| GB (1) | GB1513916A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5598423A (en) * | 1979-01-22 | 1980-07-26 | Aichi Electric Works | Changeover switch |
| US5356885A (en) * | 1991-04-24 | 1994-10-18 | American Cyanamid Company | Substituted oxotremorine derivatives and pharmaceutical use thereof |
| US5550257A (en) * | 1991-04-24 | 1996-08-27 | American Cyanamid Company | Substituted oxotremorine derivatives |
| US5521210A (en) * | 1993-04-13 | 1996-05-28 | Allergan, Inc. | Ophthalmic use of muscarinic agonists having increased duration of activity |
| MXPA04008173A (es) * | 2002-02-22 | 2004-11-26 | Pharmacia Corp | Formulaciones de farmaco antibiotico oftalmico que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3354178A (en) * | 1965-04-09 | 1967-11-21 | Sterling Drug Inc | Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides |
| US3856790A (en) * | 1970-01-06 | 1974-12-24 | American Home Prod | Cyclic amides of 1,4-diaminobut-2-yne |
| US3824313A (en) * | 1973-03-16 | 1974-07-16 | Nelson Res & Dev | Topical opthalmic composition and methods of use |
-
1974
- 1974-08-01 US US493751A patent/US3920824A/en not_active Expired - Lifetime
-
1975
- 1975-07-09 GB GB28847/75A patent/GB1513916A/en not_active Expired
- 1975-07-17 DE DE2532017A patent/DE2532017C2/de not_active Expired
- 1975-07-31 FR FR7523945A patent/FR2280373A1/fr active Granted
- 1975-08-01 JP JP50093231A patent/JPS5138411A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| FR2280373B1 (enExample) | 1979-09-14 |
| US3920824A (en) | 1975-11-18 |
| JPS5138411A (enExample) | 1976-03-31 |
| DE2532017A1 (de) | 1976-02-19 |
| FR2280373A1 (fr) | 1976-02-27 |
| DE2532017C2 (de) | 1984-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1209946A (en) | Homopyrimidazole derivatives | |
| ES8204739A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| NO2006002I2 (no) | Posakonazol eventuelt i form av en ester og/eller et farmasøytisk akseptabelt salt derav. | |
| IE41474L (en) | Thiomethylergolines | |
| GB1513916A (en) | Stable ophthalmic formulation | |
| US4780465A (en) | Aqueous solution containing a quinolone carboxylic acid | |
| GB1285400A (en) | Esters of substituted anthranilic acid | |
| GB1496491A (en) | Dihydroergopeptine derivatives | |
| GB1185096A (en) | Improvements in or relating to Antibiotic Derivatives and the manufacture thereof | |
| IE45178L (en) | Phenothiazine derivatives | |
| GB1445765A (en) | Phenoxy-substituted malonic acid derivatives their prepration and pharmaceutical compositions containing them | |
| GB1327336A (en) | Miticidal compositions | |
| GB1472084A (en) | Composition and method for sterilizing contact lenses | |
| GB1426479A (en) | Dermatological composition and method | |
| GB1347598A (en) | Lincomycin derivatives and the manufacture thereof | |
| GB1529251A (en) | 9,10-dihydroergopeptines | |
| GB1240817A (en) | Herbicidal agents | |
| CA1268183A (en) | INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS | |
| GB1174880A (en) | Derivatives of alpha-Piperazinophenylacetonitrile and process for manufacture of same | |
| SE8001981L (sv) | Kompositioner for behandling av glaukom | |
| GB1431709A (en) | Lysozyme derivatives | |
| ES363591A1 (es) | Un procedimiento para la produccion de derivados de fenile-tilamina. | |
| GB1400851A (en) | Triidothyroalkyl compounds their method of preparation and therapeutical compositions containing such compounds | |
| ES424362A1 (es) | Un proceso para la preparacion y estabilizacion de una com-posicion oftalmica, administrable topicamente. | |
| SE300011B (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |